Grace Therapeutics, Inc. — Form D

Grace Therapeutics, Inc. of Princeton, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-10. The offering totals $15.1M, of which $7.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Michael DerbyDirectorLaval, A8
Donald OldsDirectorMcLean, VA
Brian FordExecutive OfficerCharlotte, NC
Robert J. DelAversanoExecutive OfficerPrinceton, NJ
Amresh KumarExecutive OfficerPrinceton, NJ
Prashant KohliDirectorPrinceton, NJ
Prashant KohliExecutive OfficerPrinceton, NJ
Carrie D'AndreaExecutive OfficerPrinceton, NJ
S. George KottayilDirectorPrinceton, NJ
Edward NeugeborenDirectorPrinceton, NJ
A. Brian DavisDirectorWinston-Salem, NC
Dr. R. Loch MacdonaldExecutive OfficerPrinceton, NJ
Vimal KavuruDirectorPrinceton, NJ
Ronald DenisDirectorLaval, A8
Jean-Marie (John) N CananDirectorLaval, A8
Linda P O'KeefeExecutive OfficerLaval, A8
Donald N OldsDirectorLaval, A8
Roderick N CarterDirectorLaval, A8
Janelle D'AlviseDirectorLaval, A8
Janelle D'AlviseExecutive OfficerLaval, A8
Marc LebelDirectorChelmsford, MA
MARTIN GODBOUTDirectorMONTREAL, A8
Tina SampalisExecutive OfficerLAVAL, A8
Michel ChartrandDirectorLAVAL, A8
Henri HarlandDirectorLAVAL, A8

Other filings by this issuer (3)

FiledFormOfferingSold
2025-02-25D$30.0M$15.0M
2018-05-25D$838K$373K
2011-09-02D$170K

More